April Bio
April Bio is a drug development company that develops antibodies and long-acting biologics.
Funding reportedLast round: Series C
What company datasets say April Bio raised
Funding, as reported
Reported in all53Bin the source's currency
Rounds3
Last roundSeries C
Last round dateAug 2021
Investors listed20
On 3 portfolio pages
Investors who name them
Each firm lists April Bio on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
Biopharma in the same market
Startups like it
Is this your company?
Add your raise, your deck and your story, and put April Bio in front of investors. Or tell us what we have wrong.